Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jan 31:2020:9273241.
doi: 10.1155/2020/9273241. eCollection 2020.

Predicting Severe Enterovirus 71-Infected Hand, Foot, and Mouth Disease: Cytokines and Chemokines

Affiliations
Review

Predicting Severe Enterovirus 71-Infected Hand, Foot, and Mouth Disease: Cytokines and Chemokines

Weijian Zhang et al. Mediators Inflamm. .

Abstract

Enterovirus 71 (EV71) is one of the most common intestinal virus that causes hand, foot, and mouth disease (HFMD) in infants and young children (mostly ≤5 years of age). Generally, children with EV71-infected HFMD have mild symptoms that resolve spontaneously within 7-14 days without complications. However, some EV71-infected HFMD cases lead to severe complications such as aseptic meningitis, encephalitis, acute flaccid paralysis, pulmonary edema, cardiorespiratory complication, circulatory disorders, poliomyelitis-like paralysis, myocarditis, meningoencephalitis, neonatal sepsis, and even death. The mechanism of EV71 pathogenesis has been studied extensively, and the regulation of host immune responses is suspected to aggravate EV71-induced severe complications. Recently, several cytokines or chemokines such as TNF-α, IFN-γ, IL-1β, IL-18, IL-33, IL-37, IL-4, IL-13, IL-6, IL-12, IL-23, IL-27, IL-35, IL-10, IL-22, IL-17F, IL-8, IP-10, MCP-1, G-CSF, and HMGB1 have been reported to be associated with severe EV71 infection by numerous research teams, including our own. This review is aimed at summarizing the pathophysiology of the cytokines and chemokines with severe EV71 infection.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Study design and retrieval strategy.

Similar articles

Cited by

References

    1. Wang S. M., Liu C. C., Tseng H. W., et al. Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. Clinical Infecioust Diseases. 1999;29(1):184–190. doi: 10.1086/520149. - DOI - PubMed
    1. Ong K. C., Wong K. T. Understanding Enterovirus 71 neuropathogenesis and its impact on other neurotropic enteroviruses. Brain Pathology. 2015;25(5):614–624. doi: 10.1111/bpa.12279. - DOI - PMC - PubMed
    1. Schmidt N. J., Lennette E. H., Ho H. H. An apparently new enterovirus isolated from patients with disease of the central nervous system. Journal of Infectious Diseases. 1974;129(3):304–309. doi: 10.1093/infdis/129.3.304. - DOI - PubMed
    1. McMinn P., Lindsay K., Perera D., Chan H. M., Chan K. P., Cardosa M. J. Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia. Journal of Virology. 2001;75(16):7732–7738. doi: 10.1128/JVI.75.16.7732-7738.2001. - DOI - PMC - PubMed
    1. Herrero L. J., Lee C. S., Hurrelbrink R. J., Chua B. H., Chua K. B., McMinn P. Molecular epidemiology of enterovirus 71 in peninsular Malaysia, 1997-2000. Archives of Virology. 2003;148(7):1369–1385. doi: 10.1007/s00705-003-0100-2. - DOI - PubMed

LinkOut - more resources